«2.1 Анальгетики, противоревматические средства, миорелаксанты и средства от подагры 2.1.1 Парацетамол Фармакология и токсикология. Парацетамол (например, ben-u-ron®, ...»
Kramer WB, Saade G, Ou CN et al. Placental transfer of sulindac and its active sulfide metabolite in humans. Am J Obstet Gynecol 1995; 172: 886–90.
Laskin CA, Bombardier C, Hannah ME et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148–53.
Levy M, Buskila D, Gladman DD et al. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 1991; 8: 174–8.
Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327: 1–5.
Llanas B, Cavert MH, Apere H et al. Adverse effects of ketoprofen after intrauterine exposure. Value of plasma determination. Arch Pediatr 1996; 3: 248–53.
Locatelli A, Vergani P, Bellini P et al. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effect of indomethacin? BJOG 2001; 108: 325–6.
Magnani C, Moretti S, Ammenti A. Neonatal chronic failure associated with maternal ingestion of nimesulide as analgesic. Eur J Obstet Gynaecol 2004; 116: 244–5.
Major CA, Lewis DF, Harding JA et al. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol 1994; 170: 102–6.
Martinez-Frias ML, Rodriguez-Pinilla E, Bermejo E et al. Prenatal exposure to penicillamine and oral clefts: case report. Am J Med Genetics 1998; 76: L274–5.
Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997; 56: 241–3.
Mas C, Menahem S. Premature in utero closure of the ductus arteriosus following maternal ingestion of sodium diclofenac. Aust N Z J Obstet Gynaecol 1999; 39: 106–7.
McWorther J, Carlan SJ, O’Leary TD et al. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial. Obstet Gynecol 2004; 103: 923–30.
Medveczky E, Puho E, Czeizel EA. The use of drugs in mothers of offspring with neuraltube defects. Pharmacoepidemiol Drug Saf 2004; 13: 443–55.
Merck & Co. Inc: 5th annual report on exposure during pregnancy from the Merck pregnancy registry for VIOXX (rofecoxib). Covering the period from approval (May 1999) through September 30, 2004. Merck Research Labs, West Point, PA.
Messner U, Gunter HH, Niesert S. Morbus Wilson und Schwangerschaft. Literaturbersicht und kasuistische Mitteilung. Z Geburtsh Neonatol 1998; 202: 77–9.
Moise KJ Jr. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 1993; 168:
Moise KJ, Huhta JC, Sharif DS et al. Indomethacin in the treatment of premature labor, effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327–31.
Moran LR, Almeida PG, Worden S et al. Intrauterine baclofen exposure: a multidisciplinary approach. Pediatrics 2004; 114: 267–9.
Morrison CE, Dutton D, Howie H et al. Pethidine compared with meptazinol during labour. Anaesth 1987; 42: 7–14.
Motta M, Tincani A, Faden D et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 2005; 25: 86–9.
Munoz FC, Marco DG. Pregnancy outcome in a woman exposed to continous intrathecal baclofen infusion. Ann Pharmacother 2000; 34: 956.
Nicholas ADG, Robson PJ. Double-blind comparison of meptazinol and pethidine in labour. Br J Obstet Gynaecol 1982; 89: 318–22.
Nikkola EM, Ekblad UU, Kero PO et al. Intravenous fentanyl PCA during labour. Can J Anaesth 1997; 44: 1248–55.
Nielsen GL, Sorensen HT, Larsen H et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322: 266–70.
Nissen E, Widstrom AM, Lilja G et al. Effects of routinely given pethidine during labour on infants’ developing breastfeeding behaviour. Effects of dosedelivering interval and various concentrations of pethidine/norpethidine in cord plasma. Acta Paediatr 1997; 86:
Norton ME. Teratogen update: Fetal effects of indomethacin administration during pregnancy. Teratology 1997; 56: 282–92.
Norton ME, Merrill J, Cooper BAB et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602–7.
Oberlander TF, Robeson P, Ward V et al. Prenatal and breast milk morphin exposure following maternal intrathecal morphine treatment. J Hum Lact 2000; 16: 137–42.
Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 2000; 159: 153–5.
Olesen C, Steffensen FH, Sorensen HT et al. Pregnancy outcome following prescription for sumatriptan. Headache 2000; 40: 20–4.
O’Quinn S, Ephross SA, Williams V et al. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999; 263: 7–12.
Paladini D, Marasini M, Volpe P. Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide. Ultrasound Obstet Gynaecol 2005;
Pall M, Friden BE, Brnnstrm M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double blind study. Hum Reproduct 2001; 16: 1323–8.
Parilla BV, Grobman WA, Holtzman RB et al. Indomethacin tocolysis and the risk of necrotizing enterocolits. Obstet Gynecol 2000; 96: 120–3.
Parke A, West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 1996; 23: 1715–8.
Peruzzi L, Gianoglio B et al. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type I selective inhibitor nimesulide as tocolytic. Lancet 1999; 354: 1615.
Pinter R, Hogge WA, McPherson E. Infant with severe penicillamine embryopathy born to a woman with Wilson’s disease. Am J Med Genet 2004 (Part A); 128: 294–8.
Rabinovitch O, Zemer D, Kukia E et al. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial mediterranean fever.
Am J Reproduct Immunol 1992; 28: 245–6.
Radi S, Broux F, Noblet C et al. Danger du Nifluril® pendant la grossesse: un cas d’insuffisance renale chronique debut antenatal. Arch Pediatr 1999; 6: 338–9.
Ransj-Arvidson AB, Matthiesen AS, Lilja G et al. Maternal analgesia during labour disturbs newborn behavior: effects on breastfeeding, temperature, and crying. Birth 2001;
Rasanen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 1995; 173: 20–5.
86 Лекарственная терапия в период беременности Ratnayaka BDM, Dhaliwal H, Watkin S. Neonatal convulsions after withdrawal of baclofen. BMJ 2001; 323: 85.
Rayburn W, Rathke A, Leuschen MP et al. Fentanyl-citrate analgesia during labor. Am J Obstet Gynecol 1989; 161: 202–6.
Raymond GV. Teratogen update — ergot and ergotamine. Teratology 1995; 51: 344–7.
Regan J, Chambers F, Gorman W et al. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. Br J Obstet Gynaecol 2000; 107: 570–2.
Reiff-Eldridge R, Heffner C, Ephross S et al. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000; 182: 159–63.
Roberts AG, Graves CR, Konrad PE et al. Intrathecal baclofen pump implantation during pregnancy. Neurology 2003; 61: 1156.
Rosa FW. Teratogen update: penicillamine. Teratology 1986; 33: 127–31.
Rotchell YE, Cruickshanak JK, Gay MP et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of preeclampsia and its complications. Br J Obstet Gynaecol 1998: 105: 286–92.
Rumack CM, Guggenheim MA, Rumack BH et al. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 1981; 58: 52–6.
Sasidharan CK, Kutty PM, Ajithkumar et al. Fetal intracranial hemorrhage due to antenatal low-dose aspirin intake. Indian J Ped 2001; 68: 1071–2.
Sawdy RJ, Groom KM, Bennett PR. Experience of the use of nimsulide, a cyclooxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in high-risk cases. J Obstet Gynaecol 2004; 24: 226–9.
Sawdy RJ, Lye S, Fisk NM et al. A double-blind randomized study of fetal side effects during and after short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labour. Am J Obstet Gynecol 2003; 188: 1046–51.
Schaefer C. Kupfer und Penicillamin in der Schwangerschaft. Internistische Praxis 1994; 34: 436–7.
Schick B, Hom M, Tolosa J et al. Preliminary analysis of first trimester exposure to oxycodone and hydrocodone. Reprod Toxicol 1996; 10: 162.
Schmidt HHJ. Diagnostik und Therapie des Morbus Wilson. Dt rztebl 2003; 4: 171–5.
Shaheen SO, Newson RB, Henderson AJ et al. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy 2005; 35:
Shaheen SO, Newson RB, Sherriff A et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002; 57: 958–63.
Sharpe CR, Franco EL. Use of dipyrone during pregnancy and risk of Wilms’ tumor.
Brazilian Wilms’ Tumor Study Group. Epidemiology 1996; 7: 533–5.
Shuhaiber S, Pastuszak A, Schick B et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998; 51: 581–3.
Sibai BM, Caritis SN, Thom E et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213–8.
Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989; 74: 551–7.
Sills ES, Perloe M, Tucker MJ et al. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001; 46: 366–8.
Sinha S, Taly AB, Prashanth LK et al. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease. J Neurol Sci 2004; 217: 37–40.
Siu KL, Lee WH. Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension. J Paediatr Child Health 2004; 40: 152–3.
Siu SSN, Yeung JHK, Lau TK. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000; 15: 2423–5.
Siu SSN, Yeung JHK, Lau TK. An in vivo study on placental transfer of naproxen in early human pregnancy. Hum Reprod 2002; 17: 1056–9.
Sivojelezova A, Einarson A, Koren G. A prospective cohort study evaluating pregnancy outcomes and risk perceptions of pregnant women following glucosamine use during pregбеременность nancy (OTIS
session). Birth Defects Res A 2005; 73: 395.
Slone D, Siskind V, Heinonen OP. Aspirin and congenital malformations. Lancet 1976;
Smets K, Zecic A, Willems J. Ergotamine as a possible cause of Mobius sequence: additional clinical observation. J Child Neurol 2004; 19: 398.
Stika CS, Gross GA, Leguizamon G et al. A prospective randomized safety trial of celecoxib for treatment of preterm labour. Am J Obstet Gynecol 2002; 187: 653–60.
Talati AJ, Salim MA, Korones SB. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinat 2000; 17: 69–71.